E

Eve

Eve was built on AI from its founding, and says so in its design. The company was founded in 2020 for this purpose, with no earlier product to attach models to. The January 2026 relaunch as an AI Workforce is built around three agent roles, Agents, Auditor and Analyst. The June 2026 EveOS launch positions it as an operating layer for the firm rather than a tool inside one. Every deliverable is generated: intake evaluation, medical overviews, demand letters, complaints and discovery responses in both directions.

The system also adapts to a firm's writing style with use, which is model behavior, not configuration. Remove the models and nothing remains.

Eve builds grounding and checking into the product, but publishes no measurement. It says all sources for its answers are linked back to the firm's own documents, that the system checks its own responses, and that users can verify a response in one click. Self checking goes beyond showing sources, and the Auditor agent introduced in January 2026 suggests checking is a named part of the system. None of it is measured or specified.

There is no accuracy figure, no extraction recall on medical records, no hallucination rate and no evaluation. Nothing says what the self check tests, what happens when it fails, or how the system behaves when records are incomplete or contradictory. A named auditor agent with no published output describes design, not proven accuracy.

Eve makes a strong autonomy claim and builds checking in as a role, but publishes no limits. The AI Workforce is three coordinated agents that move cases forward without waiting for attorney prompts, a plain autonomy claim, and EveOS extends that to the firm's operations. The Auditor role is a named checking function within the workforce, not a caveat. That is the right design for agents that act on their own. But the limits are not described.

Nothing says what an agent may do without attorney approval, whether anything is sent or filed unattended, what triggers Auditor review, or what standard it applies. Nothing says what happens when Agent and Auditor disagree, or how a firm sets the limits. Moving live cases forward on its own is a high stakes claim, and it comes with no published limits.

Eve backs its claims with named, dated, checkable evidence. Its dated September 2025 funding announcement reports more than 450 firms, more than 350 added in eight months, more than 200,000 cases a year, and firms recovering more than $3.5 billion in settlements and judgments in total. Named customers report results with attributed comment. Frontier Law Center's managing partner, Manny Starr, quoted by name in a named publication in March 2026, reports intake conversion rising from 10 percent to 35 percent, intake time falling by 50 minutes per call, and average case value rising 90 percent.

James Scott Farrin attorneys complete medical chronologies in minutes that used to take weeks. A separate verified user reports case capacity rising up to 2.5 times without new staff. A reader can name the firm and partner, find the publication and check the date without contacting Eve. The figures have no method or baseline, and the $3.5 billion is a total of customer outcomes, not proof of Eve's contribution.

Eve addresses attorney client privilege directly. It says the platform is built with attorney client privilege as a first principle, that case data is never used to train shared models, and that data is isolated to the firm at organization, user and workflow levels. Naming three levels of isolation is a specification, not just an assurance, and isolation by workflow addresses one matter's content surfacing in another.

The credentials fit this market: SOC 2 Type 2 certification, HIPAA compliance for the claimant health information the product takes in, and AES-256 end to end encryption. Two limits: the isolation design is asserted rather than documented, and there is no attestation specific to privilege.

Not located, and the gap matters because the autonomy claim is large. Agents are stated to advance cases proactively without waiting for attorney prompts, and the product drafts complaints and discovery responses, which are filed documents bearing an attorney's signature and certification. Nothing published addresses the supervising attorney's duty over proactively advanced casework, what an attorney is certifying when signing a machine drafted pleading, the professional responsibility dimension of generated discovery responses, or any bar guidance. The Auditor agent is a quality mechanism inside the product and not a statement about the lawyer's own obligations.

Nothing published about how the models are governed, evaluated or monitored. No AI policy, no model card, no bias or fairness testing, no evaluation methodology or result, no accuracy monitoring, no drift statement, no named governance body and no ISO 42001. The risk is sharp here: this product performs case evaluation and identifies missed case value, so it makes judgments about what a claim is worth, and it does so inside an agent architecture that advances cases proactively.

A systematic tendency in valuation would propagate through 200,000 cases annually without an attorney necessarily prompting the judgment that produced it. The Auditor agent checks output within the system and is not an independent evaluation of the models.

Eve states a real data stewardship position, and openly discloses a detail it did not have to. Case data is encrypted with AES-256 end to end, never used to train shared models, and isolated to the firm at organization, user and workflow levels. Eve also says the system learns a firm's tone, language and style and adapts with use. Together these describe adaptation within each firm with no pooling across customers, and stating the second point openly is more candid than staying silent about it.

Missing: no retention period for case content or output, no deletion right at matter close, and nothing on whether firm level adaptation can be turned off. Nothing says what happens to an adapted model when a firm leaves. HIPAA compliance covers protection of claimant health data, not how it is used.

No published position located. Nothing was found on liability for AI output, warranty, service levels or remedy. The exposure is large because the autonomy is: agents that advance cases proactively can act on a matter without an attorney initiating the step, and the product drafts pleadings and discovery responses subject to filing deadlines and certification requirements. A missed deadline, a defective discovery response or an understated case valuation all carry consequences that fall on the firm and ultimately on the injured claimant, and no published vendor position addresses any of them. Enterprise agreements govern this and are not public.

No integration was found on the pages checked. There was no case management, document management, records retrieval or research integration, and no API documentation. The pages checked were the home page, the working with Eve page, the product material, press coverage of the AI Workforce and EveOS launches, and the site navigation. EveOS is described as an operating platform for the firm, which suggests Eve means to be the operating layer rather than a component that plugs into one. That is an inference, not an answer. This is an absence on the pages checked.

Nothing located beyond a generic phrase. Secure cloud infrastructure is stated and names no provider, no region and no residency commitment, and no single tenant or dedicated instance option is described. The firm level isolation the vendor does describe is a logical separation claim rather than a deployment or residency statement, and the two should not be conflated: isolated to your firm says nothing about which jurisdiction the data sits in.

For a platform holding claimant protected health information at the scale of 200,000 cases annually, residency is a question a firm's own compliance review asks directly.

Eve names its certifications and an annual audit cycle, but offers no route to anything behind them. It claims SOC 2 Type 2 certification, HIPAA compliance, AES-256 end to end encryption, secure cloud infrastructure, and policies reviewed annually by independent audits, which speaks to currency. Missing: no auditing firm is named, no examination period, scope or certificate date is published, and there is no trust center, security page or way to request documents.

Eve also calls itself the first legal AI to be SOC 2 Type 2 certified. That claim cannot be checked from any published source and says nothing about the current scope or strength of the examination.

Nothing located. No foundation model provider, model family or version is named, nothing states whether third party models sit underneath the agent architecture, and no subprocessor list was found. The commitment that case data is never used to train shared models establishes that a distinction between shared and firm scoped models exists in the architecture without identifying what either is built on. For a platform processing protected health information across 200,000 cases annually, the identity of every processor in the chain is a question a firm's HIPAA business associate diligence asks directly and it cannot be answered from public material.

No pricing published at any level. No price, no range, no unit of charge, and no indication of whether the model is per seat, per case, per matter or per firm, which matters because the product is positioned as an operational platform rather than a per document tool and the pricing unit would signal which. Independent material notes that the target segment is small to medium plaintiff firms without any published attorney count, revenue band or case volume threshold defining it, so a firm cannot self assess fit either.

The contingency fee point recorded on EvenUp and Supio applies equally: case costs are advanced against a claimant's recovery, so undisclosed pricing is undisclosed cost to an injured person.

Eve covers the whole case lifecycle and states its practice limits honestly, but does not define its target firms. Coverage runs from intake to resolution: intake and case evaluation, medical overviews and chronologies, demand letters, complaints, and discovery in both directions, so it reaches into litigation rather than stopping at the demand. Personal injury is the main focus, with medical malpractice, employment and general litigation.

Independent review found no sign of family, criminal, intellectual property or transactional work, so the scope claim holds. Missing: the target of small to medium firms has no attorney count, revenue band or case volume, as independent material notes. Nothing describes depth: which record types or formats are handled, which jurisdictions the drafting covers, or whether discovery covers both state and federal practice.